A large observational study using US healthcare claims and electronic health record data suggests that Moderna’s updated 2024 ...
(NewsNation) — Moderna reports it has received full approval from the U.S. Food and Drug Administration for its COVID-19 vaccine, Spikevax, in children six months through 11 years of age, who are at ...
As support from the U.S. government has evaporated, Moderna is leaning on an old ally to carry plans for its prospective mRNA bird flu vaccine forward. The Coalition for Epidemic Preparedness ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback